Review Article
Exosomal miRNA: Small Molecules, Big Impact in Colorectal Cancer
Table 2
Summary of exosomal miRNAs with a potential biomarker role in CRC or whose expression is associated with CRC diagnosis and progression. The main source of exosomes referred in the literature is indicated. Exosome isolation techniques employed in the diverse references are indicated with their respective exosome enrichment validation procedures. Without any other mentions, plasma and serum are to be considered from human origin.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GI cancers: gastrointestinal cancers; OptiPrep: commercial density gradient medium; TEM/SEM: electron microscopy (transmission/scanning); UC: ultracentrifugation (may include differential centrifugation steps and eventual additional filtering); WB: western blot. Total exosome isolation kit (Invitrogen), ExoQuick (System Biosciences), and qEV SEC (Izon): commercial exosome purification solution or kits. |